Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Samid

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
The Prostate|September 1, 1996
The differentiating agent phenylacetate increases prostate-specific antigen production by prostate cancer cellsR Walls, A Thibault, L Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 1994
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinomaJ G Herman, F Latif, Y Weng, et al.
Cancer|June 15, 1995
Phase I study of phenylacetate administered twice daily to patients with cancerA Thibault, D Samid, M R Cooper, et al.
Cancer Research|June 1, 1994
Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenylacetateZ Ram, D Samid, S Walbridge, et al.
Cancer Research|April 1, 1994
A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancerA Thibault, M R Cooper, W D Figg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancerA Thibault, D Samid, A C Tompkins, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
The Prostate|September 1, 1996
The differentiating agent phenylacetate increases prostate-specific antigen production by prostate cancer cellsR Walls, A Thibault, L Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 1994
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinomaJ G Herman, F Latif, Y Weng, et al.
Cancer|June 15, 1995
Phase I study of phenylacetate administered twice daily to patients with cancerA Thibault, D Samid, M R Cooper, et al.
Cancer Research|June 1, 1994
Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenylacetateZ Ram, D Samid, S Walbridge, et al.
Cancer Research|April 1, 1994
A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancerA Thibault, M R Cooper, W D Figg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancerA Thibault, D Samid, A C Tompkins, et al.
Pageof 7